NO833659L - Humant immun-interferonprotein og fremgangsmaate derav - Google Patents

Humant immun-interferonprotein og fremgangsmaate derav

Info

Publication number
NO833659L
NO833659L NO833659A NO833659A NO833659L NO 833659 L NO833659 L NO 833659L NO 833659 A NO833659 A NO 833659A NO 833659 A NO833659 A NO 833659A NO 833659 L NO833659 L NO 833659L
Authority
NO
Norway
Prior art keywords
humant
immun
procedures
interferon protein
interferon
Prior art date
Application number
NO833659A
Other languages
English (en)
Other versions
NO169725B (no
NO169725C (no
Inventor
Masakazu Kikuchi
Kyozo Tsukamoto
Tsutomu Kurokawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO833659L publication Critical patent/NO833659L/no
Publication of NO169725B publication Critical patent/NO169725B/no
Publication of NO169725C publication Critical patent/NO169725C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/71Expression systems using regulatory sequences derived from the trp-operon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NO833659A 1982-11-22 1983-10-07 Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein NO169725C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000445 WO1984002129A1 (en) 1982-11-22 1982-11-22 Human immune interferon protein and process for its preparation

Publications (3)

Publication Number Publication Date
NO833659L true NO833659L (no) 1984-05-23
NO169725B NO169725B (no) 1992-04-21
NO169725C NO169725C (no) 1992-07-29

Family

ID=13762365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833659A NO169725C (no) 1982-11-22 1983-10-07 Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein

Country Status (18)

Country Link
EP (1) EP0110044A1 (no)
JP (4) JPS59186995A (no)
KR (1) KR920001377B1 (no)
AU (1) AU570219B2 (no)
DK (1) DK164063C (no)
ES (1) ES527414A0 (no)
FI (1) FI81832C (no)
GR (1) GR79035B (no)
HU (1) HU209152B (no)
IE (1) IE57053B1 (no)
IL (1) IL69791A (no)
MC (1) MC1553A1 (no)
NO (1) NO169725C (no)
NZ (1) NZ205667A (no)
PH (1) PH20024A (no)
PT (1) PT77573B (no)
WO (1) WO1984002129A1 (no)
ZA (1) ZA837057B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JPS6034919A (ja) * 1983-08-04 1985-02-22 Green Cross Corp:The ガンマ・インタ−フェロン組成物
DE3484374D1 (de) * 1983-08-04 1991-05-08 Green Cross Corp Gamma-interferonzusammensetzung.
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
FR2556365B1 (fr) * 1983-12-09 1987-07-31 Transgene Sa Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon
DE3426077A1 (de) * 1984-07-14 1986-01-23 Dr. Karl Thomae Gmbh, 7950 Biberach Monoklonale antikoerper gegen humanes ifn-(gamma), diese antikoerper produzierende hybridzellinien, verwendung der neuen antikoerper und verfahren zu deren herstellung
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
JPH0653067B2 (ja) * 1984-09-11 1994-07-20 武田薬品工業株式会社 新規ハイブリドーマおよびその製造法
GB2164650A (en) * 1984-09-25 1986-03-26 Fujisawa Pharmaceutical Co Process for production of y-interferon
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
US4873312A (en) * 1985-04-25 1989-10-10 Amgen Method for purifying interferon and composition of matter produced thereby
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
GB8719108D0 (en) * 1987-08-12 1987-09-16 Natural Environment Res Expression vectors
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
PL356007A1 (en) 1999-11-12 2004-05-31 Maxygen Holdings Ltd Interferon gamma conjugates
YU32402A (sh) 1999-11-12 2005-03-15 Maxygen Holdings Ltd. Konjugati gama interferona
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
AU2003239774A1 (en) 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
ES2388068T3 (es) 2004-12-23 2012-10-08 Molmed Spa Producto de conjugación
CN103554215B (zh) 2007-10-30 2016-06-15 健泰科生物技术公司 通过阳离子交换层析进行的抗体纯化

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376821A (en) * 1981-04-17 1983-03-15 Meloy Laboratories, Inc. Production of human IFN-gamma (immune) interferon
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548U (ja) * 1982-01-22 1983-07-28 株式会社東海理化電機製作所 自動車用ミラ−の駆動装置
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JP2526750B2 (ja) * 1991-07-30 1996-08-21 株式会社ユアサコーポレーション リチウム二次電池

Also Published As

Publication number Publication date
EP0110044A1 (en) 1984-06-13
PT77573A (en) 1983-11-01
AU1934683A (en) 1984-06-28
JPS59186995A (ja) 1984-10-23
JPH0536414B2 (no) 1993-05-31
JPS6411639B2 (no) 1989-02-27
JPH06316532A (ja) 1994-11-15
KR920001377B1 (ko) 1992-02-11
IL69791A (en) 1994-05-30
DK430683A (da) 1984-05-23
KR840006676A (ko) 1984-12-01
ES8504938A1 (es) 1985-04-16
JPS59220190A (ja) 1984-12-11
GR79035B (no) 1984-10-02
NO169725B (no) 1992-04-21
PT77573B (en) 1986-03-18
NZ205667A (en) 1987-01-23
DK164063B (da) 1992-05-04
IE832216L (en) 1984-05-22
ZA837057B (en) 1984-04-25
WO1984002129A1 (en) 1984-06-07
FI81832B (fi) 1990-08-31
DK430683D0 (da) 1983-09-21
FI833525A (fi) 1984-05-23
NO169725C (no) 1992-07-29
JPS63211240A (ja) 1988-09-02
ES527414A0 (es) 1985-04-16
DK164063C (da) 1992-09-28
HU209152B (en) 1994-03-28
FI833525A0 (fi) 1983-09-29
IE57053B1 (en) 1992-04-08
FI81832C (fi) 1990-12-10
MC1553A1 (fr) 1984-08-31
PH20024A (en) 1986-09-01
AU570219B2 (en) 1988-03-10

Similar Documents

Publication Publication Date Title
NO833659L (no) Humant immun-interferonprotein og fremgangsmaate derav
NO801133L (no) Interferonproteiner og fremgangsmaate for fremstilling derav
DK565882A (da) Interferonpraeparater og fremgangsmaade til fremstilling heraf
DK47285A (da) Renininhiberende peptider og anvendelsen deraf
DK401583A (da) Parenkymal celle-cellulose og beslaegtede materialer
DK276683D0 (da) Carbapenemer og fremgangsmade til fremstilling deraf
DK144483D0 (da) Barbermaskine og barberingsenhed for barbermaskiner
NO882917L (no) Fusjonsproteiner og partikler.
FR2550205B1 (fr) Proteines humaines, antisera et necessaires experimentaux
KR860004915A (ko) 아미노아실라브단 및 이의 제조방법
DK158844C (da) Saltsyrepraeparater og anvendelse heraf
DK262584A (da) Interferon-gelformulering og fremgangsmaade til fremstilling heraf
DK343183D0 (da) Ketoquinoliner og fremgangsmade til fremstilling deraf
DK196088A (da) Rekombinant htlv-iii protein og anvendelse deraf
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
NO863469D0 (no) Herbicid og fremgangsmaate for anvendelse derav.
DK565783A (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin
DE3475192D1 (de) Pyrrolizidinones and indolizidones
DK238585D0 (da) Peptider og fremstilling deraf
DK363786A (da) Hydroquinoliner og anvendelse deraf
NO924995D0 (no) Humant meg-csf-protein og fremgangsmaater
DK581383A (da) 1-carboxyalkanoylperhydroindol-2-carboxylsyrer og derivater deraf
DK125786D0 (da) Peptider og fremstilling deraf
IS3269A7 (is) Ný peptíð og notkun þeirra
ATE44045T1 (de) Menschliche gamma-interferon-polypeptid.